Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMYT | AZN | AMGN | GILD | VRTX |
| Company | Amryt Pharma Plc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.71 | 194.59 | 375.90 | 147.11 | 487.95 |
| High | 14.76 | 194.59 | 375.90 | 149.30 | 487.95 |
| Low | 14.63 | 194.59 | 375.90 | 145.80 | 487.95 |
| Latest | 14.70 | 192.04 | 370.93 | 144.20 | 484.36 |
| Change | +0.01 | -1.27 | -6.71 | -1.80 | -8.02 |
| % Change | +0.07% | -0.66% | -1.78% | -1.23% | -1.63% |
| Volume | 2,389,400 | 36,372 | 3,175 | 5,552,100 | 653 |
| 20-Day Average Volume | 650,490 | 1,971,524 | 2,460,474 | 7,095,260 | 1,437,653 |
| Previous Close | 14.69 | 193.31 | 377.64 | 148.56 | 492.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.59 | 202.37 | 376.89 | 149.34 | 478.74 |
| 20-Day Raw Stochastic | 75.00% | 22.43% | 48.52% | 22.25% | 65.12% |
| 20-Day Relative Strength | 72.77 | 48.65 | 56.07 | 53.31 | 54.71 |
| Weighted Alpha | +10.40 | +30.78 | +28.45 | +37.62 | +5.16 |
| Today's Opinion | 88% Buy | 80% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 96% Buy | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.62% since 04/03/23 | -1.48% since 03/05/26 | +2.26% since 03/05/26 | -1.50% since 03/04/26 | +5.89% since 03/05/26 |
| Low | 14.58 on 04/04/23 | 189.35 on 03/09/26 | 361.70 on 03/06/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 14.76 on 04/11/23 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | +0.62% since 03/10/23 | -4.86% since 02/12/26 | +2.65% since 02/12/26 | -6.29% since 02/11/26 | +4.93% since 02/12/26 |
| Low | 14.52 on 03/16/23 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 14.76 on 04/11/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | -0.47% since 01/11/23 | +8.31% since 12/12/25 | +18.30% since 12/12/25 | +18.50% since 12/11/25 | +7.94% since 12/12/25 |
| Low | 14.52 on 03/16/23 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 14.77 on 01/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +116.18% since 10/11/22 | +22.29% since 09/12/25 | +36.00% since 09/12/25 | +23.88% since 09/11/25 | +23.68% since 09/12/25 |
| Low | 6.50 on 10/28/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 14.77 on 01/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 940,256 | 299,806,016 | 203,573,632 | 181,247,456 | 125,081,264 |
| Shares Outstanding, K | 63,963 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 222,540,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 1,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 61,126,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -20,795,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.84 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/03/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/03/23 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 734.50 | 21.29 | 17.18 | 18.23 | 30.40 |